178 related articles for article (PubMed ID: 36580964)
1. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
[TBL] [Abstract][Full Text] [Related]
4. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
5. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Wang J; Yang CL; Zou LL
Mol Clin Oncol; 2017 Nov; 7(5):885-890. PubMed ID: 29075491
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.
Luo H; Li H; Yao N; Hu L; He T
Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis.
Hu L; Kong F; Pan Y
Medicine (Baltimore); 2019 Jul; 98(28):e16356. PubMed ID: 31305429
[TBL] [Abstract][Full Text] [Related]
14. CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis.
Ding X; Yang L; Geng X; Zou Y; Wang Z; Li Y; Qi R; Wang W; Li J; Yu H
BMC Cancer; 2020 Oct; 20(1):1005. PubMed ID: 33059605
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of microRNA-210 in various carcinomas: Evidence from 19 studies.
Liu Y; Wang Y; Xu Q; Zhou X; Qin Z; Chen C; Zhang Q; Tian Y; Zhang C; Li X; Qin C
Medicine (Baltimore); 2017 Oct; 96(43):e8113. PubMed ID: 29068983
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
19. EZH2 overexpression is associated with poor prognosis in patients with glioma.
Zhang Y; Yu X; Chen L; Zhang Z; Feng S
Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological significance of long non-coding RNA in glioma.
Li J; Liang R; Song C; Xiang Y; Liu Y
Neurosurg Rev; 2020 Feb; 43(1):1-8. PubMed ID: 29564570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
